A consortium of Canadian medtech companies, led by FluidAI Medical, has launched the Postoperative Patient Management Platform (PPMP) project.
Other partners in the consortium include Medtronic Canada ULC, Excelar Technologies, Providence Health Care Ventures, and the University of Waterloo.
The new project, which builds on the success of the Continuous Connected Patient Care (CCPC) project, is part of Canada’s Global Innovation Cluster for digital technologies (DIGITAL).
It aims to advance postoperative care through advanced artificial intelligence (AI) and machine learning technologies.
DIGITAL CEO Sue Paish said: “AI will revolutionise global health care systems by providing greater access and better outcomes for Canadians and for people around the world.
“By uniting industry leaders, innovators, and academic partners, we’re building the foundation for tomorrow’s breakthroughs and ensuring Canada remains at the cutting edge of global AI innovation.
“We’re proud to co-invest alongside innovators like FluidAI to build relevant AI solutions that advance human health while building global commercial pathways for Canadian companies.”
The primary goal of the PPMP project is the development of advanced predictive analytics to forecast postoperative complications such as anastomotic leaks and respiratory depression.
The project will integrate extensive data sets from electronic health records and monitoring devices to provide actionable insights and enable surgeons to make faster and more precise decisions.
It will be initially deployed at Providence Health Care’s St. Paul’s Hospital in Vancouver, with plans to expand to other hospitals across Canada, the US, and other markets worldwide.
FluidAI CEO Youssef Helwa said: “By integrating AI and continuous monitoring into the PPMP project, we are developing a platform that not only facilitates earlier detection of complications but also sets a new precedent for proactive, data-driven patient care.
“FluidAI is proud to be leading the collaboration of Canadian medical technology pioneers on this project which highlights our collective commitment to innovation and excellence.”
FluidAI Medical is steering the development of predictive models and integrating the Stream Platform for remote patient monitoring.
Medtronic Canada is offering its vital monitoring solutions and is collaborating on the development of predictive analytics.
Excelar Technologies is enhancing its CareFlow platform to support broader use cases in AI-driven risk prediction.
Providence Health Care Ventures is facilitating feasibility trials, validating solutions, and ensuring regulatory compliance.
The University of Waterloo is conducting user needs assessments to ensure the platform meets healthcare providers’ requirements.
The new platform is expected to improve patient outcomes by enhancing patient care through early detection and intervention of postoperative complications.
It will also benefit hospitals from more effective patient management, reduced hospital stays, lower readmission rates, and significant cost savings.
Medtronic AC&M research and technology and open innovation senior director Rick Sethi said: “We are excited to be collaborating with amazing partners such as DIGITAL, FluidAI and our other consortium team members to find ways to reduce the length of stay of patients in hospitals.
“The development of our AI-based Clinical Decision Support technology will help augment patient care by supporting our clinicians.”
